SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-22-031514
Filing Date
2022-08-30
Accepted
2022-08-30 16:33:39
Documents
3
Period of Report
2022-10-18

Document Format Files

Seq Description Document Type Size
1 PRE 14A ny20005123x1_pre14a.htm PRE 14A 250129
2 ny20005123x1-pc_1.jpg GRAPHIC 537140
3 ny20005123x1-pc_2.jpg GRAPHIC 355363
  Complete submission text file 0001140361-22-031514.txt   1479828
Mailing Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 416-1192
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38470 | Film No.: 221214972
SIC: 2834 Pharmaceutical Preparations